FdaApplication
ANDA 205280
Identifiers
- fda_app_no: ANDA205280
Properties
| Property | Value |
|---|---|
| applicant_name | ORBION PHARMACEUTICALS PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2019-05-13 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RISEDRONATE SODIUM | RISEDRONATE SODIUM | 35MG | TABLET;ORAL |
| RISEDRONATE SODIUM | RISEDRONATE SODIUM | 30MG | TABLET;ORAL |
2 products